Skip to main content
TipRanks
Go Ultimate75% OFF

Ionis Pharmaceuticals (0JDI) Ownership - Who Owns Ionis Pharmaceuticals?

0 Followers

Ionis Pharmaceuticals (0JDI) Ownership Overview

  • 0.74% Insiders
  • 46.30% Mutual Funds
  • 31.31% Other Institutional Investors
  • 16.75% ETFs
  • 4.89% Public Companies and Individual Investors

The ownership structure of Ionis Pharmaceuticals (GB:0JDI) stock is a mix of institutional, retail, and individual investors. Approximately 94.37% of the company’s stock is owned by Institutional Investors, 0.74% is owned by Insiders, and 4.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 12, 2026Michael R. Hayden$148,200
Jul 30, 2026Michael R. Hayden$1,058,700
Feb 03, 2026Frank C. Bennett$7,055,489
Feb 01, 2026Eric Swayze$512,424

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Graham Capital Management, L.p.$600,919
Dec 31, 2025Gilder Gagnon Howe & Co Llc.$1,524,845
Dec 31, 2025Bridgewater Associates, Lp$5,356,221
Dec 31, 2025Fisher Asset Management Llc$11,203,162

Top Shareholders

GB:0JDI top shareholders
Holder# of SharesType% HoldingValue
Vanguard13,390,177Institution8.04%382,959,062
BlackRock, Inc.13,192,834Institution7.92%377,315,052
Fidelity Mt. Vernon Street Trust12,889,618Institution7.74%368,643,075
Vanguard Index Funds12,557,124Institution7.54%359,133,746
Growth Fund Of America7,668,655Institution4.60%219,323,533
Vanguard Specialized Funds6,212,640Institution3.73%177,681,504
Smallcap World Fund Inc5,259,919Institution3.16%150,433,683
Ishares5,145,135Institution3.09%147,150,861
New Economy Fund4,868,802Institution2.92%139,247,737
Ivy Funds3,279,894Institution1.97%93,804,968

Top Mutual Fund Holders

GB:0JDI top mutual fund holders
Holder# of SharesType% HoldingValue
Fidelity Mt. Vernon Street Trust12,889,618Institution7.74%368,643,075
Vanguard Index Funds12,557,124Institution7.54%359,133,746
Growth Fund Of America7,668,655Institution4.60%219,323,533
Vanguard Specialized Funds6,212,640Institution3.73%177,681,504
Smallcap World Fund Inc5,259,919Institution3.16%150,433,683
New Economy Fund4,868,802Institution2.92%139,247,737
Ivy Funds3,279,894Institution1.97%93,804,968
T. Rowe Price Mid-cap Growth Fund, Inc.1,998,674Institution1.20%57,162,076
Tweedy, Browne Fund Inc.1,963,162Institution1.18%56,146,433
Legg Mason Partners Investment Trust1,655,237Institution0.99%47,339,778

FAQ

Who Owns Ionis Pharmaceuticals (GB:0JDI)?
According to the latest TipRanks data, approximately 94.37% of the company's stock is held by institutional investors, 0.74% is held by insiders, and 4.89% is held by public companies and individual investors.
What percentage of Ionis Pharmaceuticals (GB:0JDI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 94.37% of Ionis Pharmaceuticals (GB:0JDI) stock is held by institutional investors: 46.30% by mutual funds, 16.75% by ETFs and 31.31% by other institutional investors.
What percentage of Ionis Pharmaceuticals (GB:0JDI) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.89% of Ionis Pharmaceuticals (GB:0JDI) stock is held by public companies and individual investors.
Who owns the most shares of Ionis Pharmaceuticals (GB:0JDI)?
Vanguard owns the most shares of Ionis Pharmaceuticals (GB:0JDI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.